Intricon will establish operations in Evolution Free Zone

August 2023, Alajuela, Costa Rica. Intricon, an internationally renowned multinational company headquartered in Minnesota, United States, with six other locations worldwide, chose Evolution Free Zone to install in Costa Rica a plant for the development and manufacture of medical devices incorporating microelectronics, biosensors and electromagnetic navigation sensors (EMN).

For Alvaro Carballo, President of CODE Development Group, the arrival of a company like Intricon to Evolution Free Zone is a positive sign of Costa Rica’s leadership and a vote of confidence in this business park, which is characterized by combining sustainability, technological innovation and human talent, to offer companies the ideal ecosystem for a successful development of their operations.

At Evolution Free Zone, we are committed to creating a business ecosystem that allows leading companies in the Life Sciences industry to operate successfully in Costa Rica. The arrival of Intricon to our park represents new opportunities for the people of the Western region and reaffirms the positioning of our country as an ideal destination for attracting Foreign Direct Investment”, highlighted Carballo.”

Carlos Wong, Managing Director of CODE Development Group, said: “Evolution Free Zone is proud that an internationally renowned company such as Intricon chose us to operate in the country. Our business park offers the latest advances in construction and technology in order to provide a sustainable and smart world-class infrastructure.”

Intricon will house world-class technology and manufacturing equipment in a first phase of 3,500 square meters, with adjacent growth opportunities of up to 15,000 square meters in the Evolution Free Zone. By opening this plant in Costa Rica, Intricon is diversifying its global supply chain and equipment to produce sensor-driven medical devices more cost-effectively and efficiently.

Companies need the increased capacity and deep expertise Intricon brings to help them meet the growing demand for custom sensor-controlled devices, and to make non-invasive, data-driven care a reality”, said Scott Longval, Chief Executive Officer of Intricon. “When it comes to these devices, Intricon has done it all and seen it all, so we can reduce and eliminate risk while accelerating time to market.

By the second half of 2024, Intricon will create an estimated 150 new job opportunities for the production of sensor-controlled devices used for medical applications.

About this, Manuel Tovar, the Minister of Foreign Trade in Costa Rica, highlighted, “In recent years, medical devices have become our main export product, making the country a regional leader and a key ally for companies of the life sciences sector. Today, Intricon, a company dedicated to the development of sensor-driven medical devices, joins this dynamic ecosystem of companies of this sector and announces their entry into one of the most innovative parks of Costa Rica, in 2024. We feel extremely proud about this great news and about providing, together with leading companies like Intricon, positive health outcomes to thousands of people worldwide.”